Patents by Inventor Travis S. Bayer

Travis S. Bayer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230200388
    Abstract: Disclosed herein are compounds or salts thereof, and compositions thereof, for increasing plant growth. Also disclosed are methods of increasing levels of plant nutrients using a compound, salt, or composition as disclosed herein. Also disclosed herein are kits comprising a compound, salt, or composition as described herein.
    Type: Application
    Filed: June 3, 2021
    Publication date: June 29, 2023
    Applicant: Sound Agriculture Company
    Inventors: Travis S. BAYER, Allison SCHWARTZ, Christian IBARRA, Shailaja CHADHA
  • Patent number: 10577358
    Abstract: Disclosed herein are plant propagation materials, methods of manufacturing, formulations and uses thereof. The plant propagation materials disclosed herein may comprise a strigolactone obtained by a biosynthetic process. The plant propagation material may comprise a chemical mimic of a strigolactone. The strigolactone may be 5-deoxystrigol. Methods of manufacturing the plant propagation materials may comprise a chemical process. Alternatively, methods of manufacturing the plant propagation material may comprise a biosynthetic process. The methods may comprise use of one or more polynucleotides. The polynucleotides may encode a metabolite. The polynucleotides may comprise one or more genes encoding one or more components of a strigolactone pathway.
    Type: Grant
    Filed: April 6, 2018
    Date of Patent: March 3, 2020
    Assignee: SOUND AGRICULTURE COMPANY
    Inventors: Eric A. Davidson, Travis S. Bayer, Oliver Windram, Yonek Hleba
  • Publication number: 20190084970
    Abstract: Disclosed herein plant propagation materials, methods of manufacturing, formulations and uses thereof. The plant propagation materials disclosed herein may comprise a strigolactone obtained by a biosynthetic process. The plant propagation material may comprise a chemical mimic of a strigolactone. The strigolactone may be 5-deoxystrigol. Methods of manufacturing the plant propagation materials may comprise a chemical process. Alternatively, methods of manufacturing the plant propagation material may comprise a biosynthetic process. The methods may comprise use of one or more polynucleotides. The polynucleotides may encode a metabolite. The polynucleotides may comprise one or more genes encoding one or more components of a strigolactone pathway.
    Type: Application
    Filed: April 6, 2018
    Publication date: March 21, 2019
    Inventors: Eric A. Davidson, Travis S. Bayer, Oliver Windram, Yonek Hleba
  • Patent number: 9994557
    Abstract: Disclosed herein plant propagation materials, methods of manufacturing, formulations and uses thereof. The plant propagation materials disclosed herein may comprise a strigolactone obtained by a biosynthetic process. The plant propagation material may comprise a chemical mimic of a strigolactone. The strigolactone may be 5-deoxystrigol. Methods of manufacturing the plant propagation materials may comprise a chemical process. Alternatively, methods of manufacturing the plant propagation material may comprise a biosynthetic process. The methods may comprise use of one or more polynucleotides. The polynucleotides may encode a metabolite. The polynucleotides may comprise one or more genes encoding one or more components of a strigolactone pathway.
    Type: Grant
    Filed: September 17, 2015
    Date of Patent: June 12, 2018
    Assignee: Asilomar Bio, Inc.
    Inventors: Eric A. Davidson, Travis S. Bayer, Oliver Windram, Yonek Hleba
  • Patent number: 9657279
    Abstract: The invention relates to systems and methods for production of compounds by yeast and other organisms. In one approach yeast engineered for production of a compound of commercial value is cultured together with a cellulosic bacteria, and the yeast uses a metabolic product produced by the bacteria as a carbon source. Methyl halides are an example of compounds that may be produced by this process. The invention also relates to production of organic compounds using genetically engineered organisms expressing a S-adenosylmethionine (SAM)-dependent methyl halide transferase. In one approach the organism, halides and a carbon source are incubated in a cultivation medium under conditions in which methyl halide is produced. The methyl halide may be collected and converted into non-halogenated organic molecules.
    Type: Grant
    Filed: November 26, 2008
    Date of Patent: May 23, 2017
    Assignee: The Regents of the University of California
    Inventors: Christopher A. Voigt, Travis S. Bayer
  • Publication number: 20160159780
    Abstract: Disclosed herein plant propagation materials, methods of manufacturing, formulations and uses thereof. The plant propagation materials disclosed herein may comprise a strigolactone obtained by a biosynthetic process. The plant propagation material may comprise a chemical mimic of a strigolactone. The strigolactone may be 5-deoxystrigol. Methods of manufacturing the plant propagation materials may comprise a chemical process. Alternatively, methods of manufacturing the plant propagation material may comprise a biosynthetic process. The methods may comprise use of one or more polynucleotides. The polynucleotides may encode a metabolite. The polynucleotides may comprise one or more genes encoding one or more components of a strigolactone pathway.
    Type: Application
    Filed: September 17, 2015
    Publication date: June 9, 2016
    Inventors: Eric A. DAVIDSON, Travis S. BAYER, Oliver WINDRAM, Yonek HLEBA
  • Patent number: 9315862
    Abstract: The invention relates to trans-acting ligand-responsive nucleic acids and uses thereof. In particular, a ligand responsive nucleic acid comprises an effector domain and an aptamer domain that is responsive to a ligand.
    Type: Grant
    Filed: October 5, 2005
    Date of Patent: April 19, 2016
    Assignee: California Institute of Technology
    Inventors: Christina D. Smolke, Travis S. Bayer
  • Patent number: 9309568
    Abstract: The invention relates to aptamer-regulated, ligand-responsive nucleic acids, or “ampliSwitches,” and uses thereof. Particular embodiments include a ligand-responsive nucleic acid that comprises a primer sequence domain and an aptamer domain that is responsive to a ligand.
    Type: Grant
    Filed: May 27, 2014
    Date of Patent: April 12, 2016
    Assignee: California Institute of Technology
    Inventors: Christina D. Smolke, Travis S. Bayer
  • Publication number: 20150274690
    Abstract: Disclosed herein plant propagation materials, methods of manufacturing, formulations and uses thereof. The plant propagation materials disclosed herein may comprise a strigolactone obtained by a biosynthetic process. The plant propagation material may comprise a chemical mimic of a strigolactone. The strigolactone may be 5-deoxystrigol. Methods of manufacturing the plant propagation materials may comprise a chemical process. Alternatively, methods of manufacturing the plant propagation material may comprise a biosynthetic process. The methods may comprise use of one or more polynucleotides. The polynucleotides may encode a metabolite. The polynucleotides may comprise one or more genes encoding one or more components of a strigolactone pathway.
    Type: Application
    Filed: October 24, 2014
    Publication date: October 1, 2015
    Inventors: Eric A. Davidson, Travis S. Bayer, Oliver Windram, Yonek Hleba
  • Patent number: 9040266
    Abstract: Disclosed is a process in which a recombinant organism, such as a yeast, expressing a heterologous S-adenosylmethionine (SAM)-dependent methyl halide transferase (MHT) protein is combined with a halide and a carbon source in a cultivation medium under conditions in which methyl formate is produced. The cell may genetically modified to express methyl formate synthase, methanol dehydrogenase and/or hydrolytic dehalogenase at levels higher than a cell of the same species that is not genetically modified. The methyl formate may be collected and used in a variety of applications. The halide may be chlorine, bromine or iodine.
    Type: Grant
    Filed: July 22, 2010
    Date of Patent: May 26, 2015
    Assignee: The Regents of the University of California
    Inventors: Christopher A. Voigt, Travis S. Bayer
  • Publication number: 20150024954
    Abstract: The invention relates to aptamer-regulated, ligand-responsive nucleic acids, or “ampliSwitches,” and uses thereof. Particular embodiments include a ligand-responsive nucleic acid that comprises a primer sequence domain and an aptamer domain that is responsive to a ligand.
    Type: Application
    Filed: May 27, 2014
    Publication date: January 22, 2015
    Applicant: CALIFORNIA INSTITUTE OF TECHNOLOGY
    Inventors: Christina D. Smolke, Travis S. Bayer
  • Patent number: 8772464
    Abstract: The invention relates to aptamer-regulated, ligand-responsive nucleic acids, or “ampliSwitches,” and uses thereof. Particular embodiments include a ligand-responsive nucleic acid that comprises a primer sequence domain and an aptamer domain that is responsive to a ligand.
    Type: Grant
    Filed: February 9, 2006
    Date of Patent: July 8, 2014
    Assignee: California Institute of Technology
    Inventors: Christina D. Smolke, Travis S. Bayer
  • Publication number: 20120258506
    Abstract: Disclosed is a process in which a recombinant organism, such as a yeast, expressing a heterologous S-adenosylmethionme (SAM)-dependent methyl halide transferase (MHT) protein is combined with a halide and a carbon source in a cultivation medium under conditions in which methyl formate is produced. The cell may genetically modified to express methyl formate synthase, methanol dehydrogenase and/or hydrolytic dehalogenase at levels higher than a cell of the same species that is not genetically modified. The methyl formate may be collected and used in a variety of applications. The halide may be chlorine, bromine or iodine.
    Type: Application
    Filed: July 22, 2010
    Publication date: October 11, 2012
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Christopher A. Voigt, Travis S. Bayer
  • Publication number: 20120035065
    Abstract: The invention relates to aptamer-regulated, ligand-responsive nucleic acids, or “ampliSwitches,” and uses thereof. Particular embodiments include a ligand-responsive nucleic acid that comprises a primer sequence domain and an aptamer domain that is responsive to a ligand.
    Type: Application
    Filed: February 9, 2006
    Publication date: February 9, 2012
    Applicant: California Institute of Technology
    Inventors: Christina D. Smolke, Travis S. Bayer
  • Publication number: 20110165618
    Abstract: The invention relates to systems and methods for production of compounds by yeast and other organisms. In one approach yeast engineered for production of a compound of commercial value is cultured together with a cellulosic bacteria, and the yeast uses a metabolic product produced by the bacteria as a carbon source. Methyl halides are an example of compounds that may be produced by this process. The invention also relates to production of organic compounds using genetically engineered organisms expressing a S-adenosylmethionine (SAM)-dependent methyl halide transferase. In one approach the organism, halides and a carbon source are incubated in a cultivation medium under conditions in which methyl halide is produced. The methyl halide may be collected and converted into non-halogenated organic molecules.
    Type: Application
    Filed: November 26, 2008
    Publication date: July 7, 2011
    Inventors: Christopher A. Voigt, Travis S. Bayer
  • Publication number: 20110151534
    Abstract: The invention relates to a process for production of organic compounds using genetically engineered organisms expressing a S-adenosylmethionine (SAM)-dependent methyl halide transferase and, optionally modified at loci that affect flux through SAM metabolic pathways or affect intracellular halide levels. In one approach the organism, halides (chlorine, bromine and/or iodine); and a carbon source are incubated in a cultivation medium under conditions in which methyl halide is produced. The methyl halide may be collected and converted into non-halogenated organic molecules.
    Type: Application
    Filed: November 26, 2008
    Publication date: June 23, 2011
    Inventors: Christopher A. Voigt, Daniel V. Santi, Travis S. Bayer